• Home
• core 10 scoring
• Updating the Canadian Hemophilia Outcomes–Kids' Life Assessment Tool (CHO‐KLAT) in the era of extended half‐life clotting factor concentrates - Research and Practice in Thrombosis and Haemostasis

Updating the Canadian Hemophilia Outcomes–Kids' Life Assessment Tool (CHO‐KLAT) in the era of extended half‐life clotting factor concentrates - Research and Practice in Thrombosis and Haemostasis

4.5 (785) · $ 19.99 · In stock

Pharmacokinetic and clinical improvements after PK-guided switch from standard half-life to extended half-life factor VIII products - Thrombosis Research

Table 2 from Optimal management of hemophilic arthropathy and hematomas

Thrombin generation and implications for hemophilia therapies: A narrative review - Research and Practice in Thrombosis and Haemostasis

Patient‐relevant health outcomes for hemophilia care: Development

Haemophilia Nature Reviews Disease Primers

WFH Guidelines For The Management of Hemophilia, 3rd Edition, PDF, Bleeding

Strategies for clotting factor replacement therapy at different ages

PDF) Nonreplacement therapy for hemophilia in low-income countries

Issues complicating precision dosing for factor VIII prophylaxis